Cargando…

A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis

Introduction Mucormycosis is a rare opportunistic fungal infection caused by fungi belonging to the Mucorales order and Mucoraceae family. It ranks as the third most prevalent angioinvasive fungal infection, following aspergillosis and candidiasis. This severe infection typically affects individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: S, Anbumathi, Govindarajan, Karthikeyan, S, Yogesh, Parivallal, Pranav Lokesh G, Hariharan, Sathyanarayana, Khaleel, Atif, SB, Praveen T, Goswami, Katyayani, Saravanan, Pushpa, Panneerselvam, Dharmarajan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684971/
https://www.ncbi.nlm.nih.gov/pubmed/38034231
http://dx.doi.org/10.7759/cureus.47932
_version_ 1785151525894488064
author S, Anbumathi
Govindarajan, Karthikeyan
S, Yogesh
Parivallal, Pranav Lokesh G
Hariharan, Sathyanarayana
Khaleel, Atif
SB, Praveen T
Goswami, Katyayani
Saravanan, Pushpa
Panneerselvam, Dharmarajan
author_facet S, Anbumathi
Govindarajan, Karthikeyan
S, Yogesh
Parivallal, Pranav Lokesh G
Hariharan, Sathyanarayana
Khaleel, Atif
SB, Praveen T
Goswami, Katyayani
Saravanan, Pushpa
Panneerselvam, Dharmarajan
author_sort S, Anbumathi
collection PubMed
description Introduction Mucormycosis is a rare opportunistic fungal infection caused by fungi belonging to the Mucorales order and Mucoraceae family. It ranks as the third most prevalent angioinvasive fungal infection, following aspergillosis and candidiasis. This severe infection typically affects individuals with compromised immune systems, including those with hematological malignancies like leukemia and lymphoma, individuals who have undergone stem cell transplants, and people with diabetes mellitus. Individuals in good health are rarely affected, making immunocompromised individuals particularly vulnerable to this potentially fatal fungal disease. The aim of this study was to perform a comparative analysis of survivors versus non-survivors among diabetes patients admitted with mucormycosis. Methodology This was a descriptive observational study. A total of 338 patients were enrolled in the study. The study variables included demographics, COVID-19 infection, diabetes mellitus history, steroid use, use of oxygen support, and steam inhalation. Results Of the total 338 patients enrolled in the study, 253 (74.9%) were male and 85 (25.01%) were female. The number of survivors were 305 (90.2%) and non-survivors were 33(9.8%). The mean age of survivors was 52.50 ± 11.31 and non-survivors was 54.06 ± 8.54 years. Patients who underwent steam inhalation had a higher chance of survival compared to those who did not undergo steam inhalation and this association was statistically significant (p=0.01). Males showed a higher chance of survival (93.7%) as compared to females (80.0%). The associations between oxygen support, steroid use, and COVID-19 infection with the survival status were statistically non-significant. Conclusion There was a strong association between the history of steam inhalation and the outcome of mucormycosis among diabetes patients admitted with mucormycosis. Female patients demonstrated a higher fatality rate than males indicating a significant gender disparity observed in cases. Our findings may help to better identify and treat patients who are at higher risk for severe forms of mucormycosis.
format Online
Article
Text
id pubmed-10684971
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-106849712023-11-30 A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis S, Anbumathi Govindarajan, Karthikeyan S, Yogesh Parivallal, Pranav Lokesh G Hariharan, Sathyanarayana Khaleel, Atif SB, Praveen T Goswami, Katyayani Saravanan, Pushpa Panneerselvam, Dharmarajan Cureus Endocrinology/Diabetes/Metabolism Introduction Mucormycosis is a rare opportunistic fungal infection caused by fungi belonging to the Mucorales order and Mucoraceae family. It ranks as the third most prevalent angioinvasive fungal infection, following aspergillosis and candidiasis. This severe infection typically affects individuals with compromised immune systems, including those with hematological malignancies like leukemia and lymphoma, individuals who have undergone stem cell transplants, and people with diabetes mellitus. Individuals in good health are rarely affected, making immunocompromised individuals particularly vulnerable to this potentially fatal fungal disease. The aim of this study was to perform a comparative analysis of survivors versus non-survivors among diabetes patients admitted with mucormycosis. Methodology This was a descriptive observational study. A total of 338 patients were enrolled in the study. The study variables included demographics, COVID-19 infection, diabetes mellitus history, steroid use, use of oxygen support, and steam inhalation. Results Of the total 338 patients enrolled in the study, 253 (74.9%) were male and 85 (25.01%) were female. The number of survivors were 305 (90.2%) and non-survivors were 33(9.8%). The mean age of survivors was 52.50 ± 11.31 and non-survivors was 54.06 ± 8.54 years. Patients who underwent steam inhalation had a higher chance of survival compared to those who did not undergo steam inhalation and this association was statistically significant (p=0.01). Males showed a higher chance of survival (93.7%) as compared to females (80.0%). The associations between oxygen support, steroid use, and COVID-19 infection with the survival status were statistically non-significant. Conclusion There was a strong association between the history of steam inhalation and the outcome of mucormycosis among diabetes patients admitted with mucormycosis. Female patients demonstrated a higher fatality rate than males indicating a significant gender disparity observed in cases. Our findings may help to better identify and treat patients who are at higher risk for severe forms of mucormycosis. Cureus 2023-10-29 /pmc/articles/PMC10684971/ /pubmed/38034231 http://dx.doi.org/10.7759/cureus.47932 Text en Copyright © 2023, S et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
S, Anbumathi
Govindarajan, Karthikeyan
S, Yogesh
Parivallal, Pranav Lokesh G
Hariharan, Sathyanarayana
Khaleel, Atif
SB, Praveen T
Goswami, Katyayani
Saravanan, Pushpa
Panneerselvam, Dharmarajan
A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis
title A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis
title_full A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis
title_fullStr A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis
title_full_unstemmed A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis
title_short A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis
title_sort comparative study on survivors versus non-survivors among diabetic patients having mucormycosis
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684971/
https://www.ncbi.nlm.nih.gov/pubmed/38034231
http://dx.doi.org/10.7759/cureus.47932
work_keys_str_mv AT sanbumathi acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT govindarajankarthikeyan acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT syogesh acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT parivallalpranavlokeshg acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT hariharansathyanarayana acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT khaleelatif acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT sbpraveent acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT goswamikatyayani acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT saravananpushpa acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT panneerselvamdharmarajan acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT sanbumathi comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT govindarajankarthikeyan comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT syogesh comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT parivallalpranavlokeshg comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT hariharansathyanarayana comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT khaleelatif comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT sbpraveent comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT goswamikatyayani comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT saravananpushpa comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis
AT panneerselvamdharmarajan comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis